Indications
| Indication | Clinical Context |
|---|---|
| Enlarging or persistent pulmonary nodule/mass ≥1 cm | Evaluate for primary or metastatic malignancy; provides tissue for molecular profiling required for targeted therapy selection |
| Suspected pulmonary infection | Pneumonia not responding to treatment; FNA can identify bacterial, fungal, or mycobacterial organisms when bronchoscopy is non-diagnostic |
| Non-infectious inflammatory process | Suspected sarcoidosis, organizing pneumonia, or vasculitis with peripheral or pleural-based distribution not accessible by bronchoscopy |
| Mediastinal or pleural-based mass | CT-guided biopsy when endobronchial or surgical access is unfavorable |
Contraindications
| Type | Contraindication |
|---|---|
| Absolute | INR ≥1.5; platelets ≤50,000/µL; patient unable to cooperate or hold breath on command |
| Relative | Severe emphysema or bullous disease adjacent to planned trajectory; severe pulmonary hypertension; oxygen dependence at baseline; contralateral pneumonectomy (pneumothorax could be immediately fatal — requires rigorous risk-benefit discussion) |
Alternatives to consider first: Bronchoscopy or BAL for central or hilar masses accessible endobronchially; EBUS for lesions adjacent to major airways; VATS for peripheral lesions requiring resection; biopsy of safer extrathoracic or mediastinal disease if present and equally diagnostic.
Relevant Anatomy
Trajectory Planning Principles
The needle trajectory is the most critical decision in CT-guided lung biopsy. Prone positioning is preferred for posterior and lateral lesions — it reduces chest wall motion with respiration and allows the patient to recover in the supine position, which acts as positional therapy for small pneumothoraces. The skin entry site should be at the midpoint of CT slices showing the planned path to the target. Medial-to-lateral trajectories are preferred when feasible, as rib motion is reduced medially.
For necrotic or cavitated lesions, target the viable peripheral wall. For large mixed lesions, PET-avid areas reliably identify viable tumor and exclude necrotic tissue, and should guide needle placement when available. Entry angle should be greater than 30 degrees from the pleural surface to prevent the needle from sliding along the pleura.
Structures to Avoid
Fissures are the highest-priority structure to avoid — a trajectory crossing a major or minor fissure significantly increases pneumothorax risk. Identify all fissure locations on the planning CT before finalizing the approach. Bullae and emphysematous lung adjacent to the planned tract carry a very high risk of sustained air leak and should be avoided. From the chest wall, the intercostal neurovascular bundle runs along the inferior margin of each rib — always approach along the superior rib margin when passing between ribs. Internal mammary and axillary vessels must be avoided on medial and lateral approaches, respectively.
Pre-Procedure Checklist
Imaging Review
- Review prior CT (preferably contrast-enhanced) at the target level — identify necrosis, vessels, fissure locations, and bullae along planned trajectory
- PET-CT if available for large or heterogeneous lesions — target highest FDG-uptake region to avoid necrotic tissue
- Confirm target is growing, not resolving (compare to prior imaging)
Labs and Patient Assessment
- CBC, coagulation panel (INR <1.5, platelets >100,000 preferred), basic metabolic panel
- ECG for patients >65 years or with cardiac history
- Document baseline respiratory status — oxygen saturation, prior lung function testing if available
- Confirm ability to lie prone for over one hour
- Review medications — anticoagulation hold per SIR Category 2 guidelines
- Assess cough severity — significant cough is a relative risk factor and should be addressed before the procedure
Consent Considerations
Discuss the following with the patient: pneumothorax (~30%; ~5% require chest tube placement), hemoptysis (minor in 3–5%; significant in <1% and usually self-limited), hemothorax (<1%), air embolism (rare but potentially catastrophic — risk with open needle hub), infection, and tumor seeding (extremely rare when coaxial technique is used).
Procedure Overview
The following is a high-level summary. Full step-by-step technique, equipment selection, and troubleshooting are available in RadCall Pro.
- Positioning and planning scan — position patient prone (preferred) or supine; obtain planning CT through the target to select needle entry site and trajectory; confirm trajectory avoids fissures, bullae, and vascular structures
- Skin prep and local anesthesia — mark skin entry site; sterile prep and drape; infiltrate local anesthesia from skin through chest wall to the pleural surface under CT guidance; confirm pleural-level anesthesia before proceeding
- Coaxial introducer to pre-pleural position — advance the coaxial introducer needle to a position just short of the pleura under stepwise CT; confirm pre-pleural position before crossing
- Pleural crossing — advance the introducer through the pleural surface in a single deliberate motion; do not withdraw the needle back across the pleura after crossing
- Needle positioning in target — advance introducer tip to the target lesion under stepwise CT; keep needle hub sealed during all exchanges to prevent air entry
- Sampling passes — perform FNA passes (for cytology or microbiology) and core biopsy passes through the coaxial introducer; obtain at least 2–3 cores; target the viable periphery of large lesions
- Post-biopsy CT — obtain CT immediately after the final pass to assess for pneumothorax and pulmonary hemorrhage before moving the patient
- Specimen handling — submit core biopsy in formalin for histology; fresh tissue in saline if lymphoma or infection is suspected; coordinate with pathology in advance regarding container requirements
Complications
| Complication | Rate | Recognition & Management |
|---|---|---|
| Pneumothorax | ~30% overall; ~5% require intervention | Detected on post-biopsy CT; small and stable — supplemental O₂ and 2–4h observation with repeat CXR; enlarging or symptomatic — aspiration or small-bore chest tube placement |
| Hemoptysis | Minor 3–5%; significant <1% | Usually self-limited; position patient biopsy-side down to protect contralateral lung; supplemental O₂; bronchoscopy for massive hemoptysis |
| Pulmonary hemorrhage | Common on post-CT; clinical significance rare | Expected finding on post-procedure CT; monitor for hemoptysis; typically self-limited |
| Hemothorax | <1% | Blood in pleural space; may require thoracentesis or chest tube if symptomatic or expanding |
| Air embolism | Rare | Catastrophic; caused by open needle hub; immediate left lateral decubitus + Trendelenburg; hyperbaric oxygen; prevented by keeping hub sealed during all exchanges |
| Infection/empyema | <1% | Prophylactic antibiotics not routinely indicated; treat with antibiotics and drainage if empyema develops |
Post-Procedure Care
Monitoring
- Vitals every 30 minutes for 2 hours post-procedure; continuous oxygen saturation monitoring
- 2-hour post-procedure chest X-ray — if no pneumothorax and patient is asymptomatic, discharge may be considered
- Pain assessment — pleuritic chest pain may indicate pneumothorax or hemorrhage
- For patients with emphysema or other high-risk features: 4-hour observation minimum; low threshold to extend observation even without immediate post-procedure pneumothorax
Discharge and Follow-up
- Discharge instructions: no strenuous activity for 24 hours; return to ED for increasing chest pain, shortness of breath, or hemoptysis
- Pathology results typically available in 2–5 business days; notify ordering team and follow up with patient
- Molecular profiling results (EGFR, ALK, PD-L1, etc.) may take 1–2 additional weeks depending on lab
When to Escalate
- Enlarging or symptomatic pneumothorax — aspiration through the introducer if still in place; if removed, place small-bore chest tube in IR suite; emergent chest surgery consultation for tension pneumothorax
- Significant hemoptysis — position biopsy-side down; supplemental O₂; emergent bronchoscopy consultation; embolization for persistent arterial source
- Suspected air embolism (sudden neurologic change, cardiac collapse) — left lateral decubitus + Trendelenburg immediately; 100% O₂; emergent hyperbaric chamber consultation
- Contralateral pneumonectomy with pneumothorax — immediate emergent chest surgery consultation; any pneumothorax in this setting is potentially life-threatening
References
- ACR-SIR Practice Parameter for Percutaneous Transthoracic Lung Biopsy.
- Yeow KM, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest. 2004;126(3):748–754.
- Bourgouin PP, Rodriguez KJ, Fintelmann FJ. Tech Vasc Interv Radiol. 2021;24:100770.